Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort
Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort. // European Journal of Obstetrics & Gynecology and Reproductive Biology. – URL: https://www.sciencedirect.com/science/article/pii/S0301211526005749?dgcid=rss_sd_all
Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://www.sciencedirect.com/science/article/pii/S0301211526005749?dgcid=rss_sd_all
“Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort.” European Journal of Obstetrics & Gynecology and Reproductive Biology.
@article{article93765,
title = {Maternal and neonatal outcomes in pregnancies with cystic fibrosis after lung transplantation or during elexacaftor/tezacaftor/ivacaftor (ETI) therapy: a single-center descriptive cohort},
journal = {European Journal of Obstetrics \& Gynecology and Reproductive Biology},
url = {https://www.sciencedirect.com/science/article/pii/S0301211526005749?dgcid=rss_sd_all}
}